NZ Lymphoma / Leukaemia Research Review Issue 24

In this issue:

Atorvastatin for GVHD prevention in SCT donors and recipients

Leukaemia selection
Allogeneic SCT with RIC following FLAMSA for refractory/relapsed AML
Azacitidine and gemtuzumab in older patients with AML

Lymphoma selection
Rituximab vs. observation after R-FND in elderly advanced FL
Lenalidomide in MCL after bortezomib failure
Low-intensity therapy in Burkitt’s lymphoma
Autologous SCT as consolidation for aggressive non-Hodgkin’s lymphoma
Enhanced IPI for DLBCL in the rituximab era
Breast implant-associated anaplastic large-cell lymphoma

Please login below to download this issue (PDF)